The preclinical profiles and the clinical efficacy and safety of vornorexant (Vorzzz® tablets), a new orexin receptor antagonist
Released on J-STAGE: May 01, 2026 |
Volume 161
Issue 3
Pages 192-197
Haruka Yokota, Yukihiro Chino, Kayoko Shibayama, Shigeyuki Chaki, Yumiko Imadera